Plasma fatty acid metabolic profiling and biomarkers of type 2 diabetes mellitus based on GC/MS and PLS‐LDA

[1]  Masataka Harada,et al.  Free fatty acids regulate insulin secretion from pancreatic β cells through GPR40 , 2003, Nature.

[2]  Guowang Xu,et al.  Discrimination of Type 2 diabetic patients from healthy controls by using metabonomics method based on their serum fatty acid profiles. , 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[3]  P. Strålfors,et al.  PPAR-γ response element activity in intact primary human adipocytes: effects of fatty acids , 2006 .

[4]  C. Kahn,et al.  Insulin signalling and the regulation of glucose and lipid metabolism , 2001, Nature.

[5]  D. Behan,et al.  The use of constitutively active GPCRs in drug discovery and functional genomics , 2002, Nature Reviews Drug Discovery.

[6]  U. Das,et al.  Long-chain polyunsaturated fatty acids and chemically induced diabetes mellitus: effect of omega-6 fatty acids. , 2003, Nutrition.

[7]  Jianren Gu,et al.  Plasma phospholipid metabolic profiling and biomarkers of type 2 diabetes mellitus based on high-performance liquid chromatography/electrospray mass spectrometry and multivariate statistical analysis. , 2005, Analytical chemistry.

[8]  G. Boden.  Free fatty acids, insulin resistance, and type 2 diabetes mellitus. , 1999, Proceedings of the Association of American Physicians.

[9]  Julian L Griffin,et al.  Metabonomics: NMR spectroscopy and pattern recognition analysis of body fluids and tissues for characterisation of xenobiotic toxicity and disease diagnosis. , 2003, Current opinion in chemical biology.

[10]  Travis Dunckley,et al.  Discovery and development of biomarkers of neurological disease. , 2005, Drug discovery today.

[11]  J. Girard.  [Contribution of free fatty acids to impairment of insulin secretion and action: mechanism of beta-cell lipotoxicity]. , 2005, Medecine sciences : M/S.

[12]  K. Wyne.  Free fatty acids and type 2 diabetes mellitus. , 2003, The American journal of medicine.

[13]  F. Hsu,et al.  Characterization of phosphatidylethanolamine as a lithiated adduct by triple quadrupole tandem mass spectrometry with electrospray ionization. , 2000, Journal of mass spectrometry : JMS.

[14]  F Baganz,et al.  Systematic functional analysis of the yeast genome. , 1998, Trends in biotechnology.

[15]  J. Rood,et al.  Effects of diets enriched in saturated (palmitic), monounsaturated (oleic), or trans (elaidic) fatty acids on insulin sensitivity and substrate oxidation in healthy adults. , 2002, Diabetes care.

[16]  G. Reaven,et al.  Role of abnormal free fatty acid metabolism in the development of non-insulin-dependent diabetes mellitus. , 1988, The American journal of medicine.

[17]  F. Karpe,et al.  The effects of rosiglitazone on fatty acid and triglyceride metabolism in type 2 diabetes , 2004, Diabetologia.

[18]  Qing-Song Xu,et al.  Generalized PLS regression , 2001 .

[19]  B. Barshop.  Metabolomic approaches to mitochondrial disease: correlation of urine organic acids. , 2004, Mitochondrion.

[20]  Ross D. King,et al.  Application of metabolomics to plant genotype discrimination using statistics and machine learning , 2002, ECCB.

[21]  R. Bro,et al.  Centering and scaling in component analysis , 2003 .

[22]  Margaretha Adolfsson-Erici,et al.  Using NMR metabolomics to identify responses of an environmental estrogen in blood plasma of fish. , 2006, Aquatic toxicology.

[23]  J. McGill,et al.  Thiazolidinediones enhance insulin-mediated suppression of fatty acid flux in type 2 diabetes mellitus. , 2002, Metabolism: clinical and experimental.

[24]  J. Griffin,et al.  Choline containing metabolites during cell transfection: an insight into magnetic resonance spectroscopy detectable changes , 2001, FEBS letters.

[25]  Chan Soo Shin,et al.  The effects of rosiglitazone and metformin on the plasma concentrations of resistin in patients with type 2 diabetes mellitus. , 2005, Metabolism: clinical and experimental.

[26]  J. Lindon,et al.  Metabonomics: a platform for studying drug toxicity and gene function , 2002, Nature Reviews Drug Discovery.

[27]  G. Boden,et al.  Effects of fat on glucose uptake and utilization in patients with non-insulin-dependent diabetes. , 1995, The Journal of clinical investigation.

[28]  Philip K. Hopke,et al.  Discarding or downweighting high-noise variables in factor analytic models , 2003 .

[29]  U. Das,et al.  Long-chain polyunsaturated fatty acids and chemically induced diabetes mellitus , 2003 .

[30]  V. Lobjois.  « Cycler » sans cycline D , 2005 .

[31]  E. Ferrannini.  Rosiglitazone and lipid metabolism , 2004, Diabetologia.

[32]  Michael Stumvoll,et al.  Type 2 diabetes: principles of pathogenesis and therapy , 2005, The Lancet.

[33]  Ming Chen,et al.  A medical bioinformatics approach for metabolic disorders: Biomedical data prediction, modeling, and systematic analysis , 2006, J. Biomed. Informatics.

[34]  H. Lebovitz,et al.  Treatment of insulin resistance in diabetes mellitus. , 2004, European journal of pharmacology.

[35]  M. Matsuda,et al.  Effect of rosiglitazone on glucose and non-esterified fatty acid metabolism in Type II diabetic patients , 2001, Diabetologia.

[36]  D. Eizirik,et al.  Inverse relationship between cytotoxicity of free fatty acids in pancreatic islet cells and cellular triglyceride accumulation. , 2001, Diabetes.

[37]  P. Styles,et al.  Study of cytokine induced neuropathology by high resolution proton NMR spectroscopy of rat urine , 2004, FEBS letters.

[38]  Jian Wang,et al.  Free Fatty Acids Inhibit Insulin Signaling–Stimulated Endothelial Nitric Oxide Synthase Activation Through Upregulating PTEN or Inhibiting Akt Kinase , 2006, Diabetes.

[39]  O. Fiehn.  Metabolomics – the link between genotypes and phenotypes , 2004, Plant Molecular Biology.

[40]  P. Strålfors,et al.  PPAR-gamma response element activity in intact primary human adipocytes: effects of fatty acids. , 2006, Nutrition.

[41]  L. Mueller,et al.  Metabolomic analysis using optimized NMR and statistical methods. , 2006, Analytical biochemistry.

[42]  H. Sauter,et al.  Metabolic profiling of plants: a new diagnostic technique , 1991 .

[43]  U. Das,et al.  Long-chain polyunsaturated fatty acids and chemically induced diabetes mellitus. Effect of omega-3 fatty acids. , 2003, Nutrition.

[44]  R. Bergman,et al.  Free Fatty Acids and Pathogenesis of Type 2 Diabetes Mellitus , 2000, Trends in Endocrinology & Metabolism.